Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| GTP-Binding Protein gamma Subunits | 5 | 2023 | 10 | 0.600 |
Why?
|
| GTP-Binding Protein beta Subunits | 5 | 2023 | 17 | 0.600 |
Why?
|
| Group X Phospholipases A2 | 2 | 2009 | 2 | 0.360 |
Why?
|
| Lipoproteins, LDL | 2 | 2010 | 119 | 0.360 |
Why?
|
| Endoplasmic Reticulum | 1 | 2010 | 266 | 0.270 |
Why?
|
| Platelet Activating Factor | 1 | 2006 | 49 | 0.240 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 612 | 0.240 |
Why?
|
| Phospholipases A | 1 | 2006 | 98 | 0.240 |
Why?
|
| Cell Nucleus | 4 | 2023 | 619 | 0.230 |
Why?
|
| Vegetables | 1 | 2026 | 170 | 0.220 |
Why?
|
| Conservation of Natural Resources | 1 | 2026 | 132 | 0.220 |
Why?
|
| Endothelial Cells | 1 | 2010 | 870 | 0.200 |
Why?
|
| Coronary Artery Disease | 1 | 2009 | 741 | 0.190 |
Why?
|
| Transcription, Genetic | 3 | 2023 | 1496 | 0.190 |
Why?
|
| Biodiversity | 1 | 2026 | 426 | 0.180 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2009 | 2365 | 0.160 |
Why?
|
| Myocardium | 2 | 2023 | 939 | 0.150 |
Why?
|
| RNA Polymerase II | 1 | 2023 | 351 | 0.150 |
Why?
|
| Diet | 1 | 2026 | 1275 | 0.140 |
Why?
|
| Fibroblasts | 1 | 2023 | 1034 | 0.130 |
Why?
|
| Signal Transduction | 4 | 2023 | 5233 | 0.130 |
Why?
|
| Gene Expression Regulation | 2 | 2023 | 2609 | 0.110 |
Why?
|
| Receptors, Muscarinic | 1 | 2015 | 20 | 0.110 |
Why?
|
| Chromatography, Affinity | 1 | 2015 | 85 | 0.110 |
Why?
|
| Cytosol | 1 | 2015 | 227 | 0.100 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2015 | 210 | 0.100 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2015 | 233 | 0.090 |
Why?
|
| Small Molecule Libraries | 1 | 2013 | 111 | 0.090 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2015 | 577 | 0.090 |
Why?
|
| Carrier Proteins | 1 | 2015 | 737 | 0.080 |
Why?
|
| Activating Transcription Factor 6 | 1 | 2010 | 21 | 0.080 |
Why?
|
| Phospholipases A2, Secretory | 1 | 2010 | 14 | 0.080 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2010 | 33 | 0.080 |
Why?
|
| Umbilical Veins | 1 | 2010 | 59 | 0.080 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2010 | 24 | 0.080 |
Why?
|
| Unfolded Protein Response | 1 | 2010 | 60 | 0.080 |
Why?
|
| Transcription Factor AP-1 | 1 | 2010 | 79 | 0.080 |
Why?
|
| Gene Expression | 1 | 2015 | 1490 | 0.080 |
Why?
|
| Endoribonucleases | 1 | 2010 | 80 | 0.080 |
Why?
|
| Fluoroimmunoassay | 1 | 2009 | 4 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2010 | 370 | 0.070 |
Why?
|
| Gene Silencing | 1 | 2010 | 205 | 0.070 |
Why?
|
| 5' Untranslated Regions | 1 | 2009 | 59 | 0.070 |
Why?
|
| Interleukin-8 | 1 | 2010 | 271 | 0.070 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2009 | 381 | 0.070 |
Why?
|
| Microscopy, Confocal | 1 | 2009 | 321 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 758 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 983 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2010 | 1187 | 0.070 |
Why?
|
| Group V Phospholipases A2 | 1 | 2006 | 2 | 0.060 |
Why?
|
| Phospholipases A2 | 1 | 2006 | 79 | 0.060 |
Why?
|
| Hydrolysis | 1 | 2006 | 199 | 0.060 |
Why?
|
| Atherosclerosis | 1 | 2010 | 409 | 0.060 |
Why?
|
| Interleukin-6 | 1 | 2010 | 780 | 0.060 |
Why?
|
| Phosphatidylcholines | 1 | 2006 | 131 | 0.060 |
Why?
|
| Substrate Specificity | 1 | 2006 | 392 | 0.060 |
Why?
|
| Food Supply | 1 | 2026 | 90 | 0.060 |
Why?
|
| Immunohistochemistry | 1 | 2009 | 1718 | 0.060 |
Why?
|
| Rats | 3 | 2023 | 5614 | 0.050 |
Why?
|
| Swine | 1 | 2006 | 833 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2006 | 1371 | 0.050 |
Why?
|
| Angiotensin II | 1 | 2023 | 97 | 0.050 |
Why?
|
| Cells, Cultured | 1 | 2010 | 4155 | 0.050 |
Why?
|
| Animals | 6 | 2023 | 38109 | 0.040 |
Why?
|
| Binding Sites | 2 | 2015 | 1331 | 0.040 |
Why?
|
| Fibrosis | 1 | 2023 | 548 | 0.040 |
Why?
|
| Humans | 9 | 2026 | 144957 | 0.040 |
Why?
|
| Cell Line | 2 | 2015 | 2882 | 0.030 |
Why?
|
| Cholinergic Agonists | 1 | 2015 | 8 | 0.030 |
Why?
|
| Carbachol | 1 | 2015 | 17 | 0.030 |
Why?
|
| Receptor, Muscarinic M3 | 1 | 2015 | 3 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2015 | 138 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2015 | 175 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2015 | 214 | 0.030 |
Why?
|
| RNA Interference | 1 | 2015 | 476 | 0.020 |
Why?
|
| Calcium Signaling | 1 | 2015 | 252 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2015 | 311 | 0.020 |
Why?
|
| Transfection | 1 | 2015 | 940 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2015 | 383 | 0.020 |
Why?
|
| Organelles | 1 | 2013 | 57 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2015 | 744 | 0.020 |
Why?
|
| Drug Discovery | 1 | 2013 | 155 | 0.020 |
Why?
|
| Species Specificity | 1 | 2013 | 574 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 2032 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2015 | 1258 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2010 | 196 | 0.020 |
Why?
|
| Aged | 1 | 2009 | 25947 | 0.020 |
Why?
|
| Lipoproteins | 1 | 2010 | 169 | 0.020 |
Why?
|
| Phylogeny | 1 | 2013 | 1019 | 0.020 |
Why?
|
| Transcriptome | 1 | 2015 | 1046 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 1786 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2013 | 1619 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2015 | 2832 | 0.020 |
Why?
|
| Middle Aged | 1 | 2009 | 35928 | 0.020 |
Why?
|
| Adult | 1 | 2009 | 40506 | 0.010 |
Why?
|
| Male | 1 | 2009 | 72406 | 0.010 |
Why?
|
| Female | 1 | 2009 | 78376 | 0.010 |
Why?
|
| Inflammation | 1 | 2010 | 2880 | 0.010 |
Why?
|
| Mice | 1 | 2010 | 18365 | 0.010 |
Why?
|